# Efficacy and Safety of Hyaluronic Acid Injection on Symptoms of Vulvovaginal Atrophy in Postmenopausal Women

> **NCT04219722** · NA · COMPLETED · sponsor: **Laboratoires Vivacy** · enrollment: 121 (actual)

## Conditions studied

- Vulvovaginal Atrophy

## Interventions

- **DEVICE:** Injection of DESIRIAL®
- **OTHER:** Injection of placebo

## Key facts

- **NCT ID:** NCT04219722
- **Lead sponsor:** Laboratoires Vivacy
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-21
- **Primary completion:** 2021-09-29
- **Final completion:** 2022-06-18
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04219722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04219722, "Efficacy and Safety of Hyaluronic Acid Injection on Symptoms of Vulvovaginal Atrophy in Postmenopausal Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04219722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*